Annual CFO
$9.62B$1.84B+23.66%
Summary
- Current Value
- As of today, GSK annual cash from operations is $9.62B, up +23.66% on
- Historical Performance
- GSK annual cash from operations is up +17.94% over the past 3 years, down -1.85% over the past 5 years
- All-Time High Comparison
- GSK annual cash from operations is currently -23.18% below its historical high of $12.53B set on
- 3-Year Low Comparison
- GSK annual cash from operations is +23.66% above its 3-year low of $7.78B reached on
- Sector Comparison
- GSK annual cash from operations is higher than 98.71% of companies in Healthcare sector
Cash From Operations Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash From Operations | $9.62B | +23.7% | +17.9% | -1.9% | +1.4% | |
| Quarterly Cash From Operations | $1.48B | +4.3% | +1185.2% | +340.9% | -3.3% | |
| TTM Cash From Operations | $9.72B | +20.2% | +98.6% | +8.2% | +25.2% | |
| Price | $49.81 | +36.0% | +37.3% | +27.9% | +13.3% | |
| Annual Cash From Investing | -$5.90B | -232.2% | +45.8% | -319.6% | -91.7% | |
| Annual Cash From Financing | -$3.96B | +24.4% | -293.4% | +66.7% | +46.5% | |
| Annual Free Cash Flow | $5.69B | +43.2% | +5.8% | -17.9% | -18.3% | |
| Annual CAPEX | $3.93B | +3.2% | +41.4% | +37.0% | +55.9% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% |
Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.62B | at high | |
| 5Y | $9.91B | -2.8% | |
| All | $12.53B | -23.2% |
Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $7.78B | +23.7% | |
| 5Y | $7.78B | +23.7% | |
| All | $1.75B | +449.3% |
Cash From Operations History
FAQ
What is the current annual cash from operations of GSK?
As of today, GSK annual cash from operations is $9.62B
What is 1-year change in GSK annual cash from operations?
GSK annual cash from operations is up +23.66% year-over-year
What is 3-year change in GSK annual cash from operations?
GSK annual cash from operations is up +17.94% over the past 3 years
How far is GSK annual cash from operations from its all-time high?
GSK annual cash from operations is currently -23.18% below its historical high of $12.53B set on December 31, 2008
How does GSK annual cash from operations rank versus sector peers?
GSK annual cash from operations is higher than 98.71% of companies in Healthcare sector
When is GSK next annual earnings release?
As of today, the next annual earnings release for GSK has not been scheduled
Quarterly CFO
$1.48B$1.26B-45.93%
Summary
- Current Value
- As of today, GSK quarterly cash from operations is $1.48B, down -45.93% on
- Historical Performance
- GSK quarterly cash from operations is up +4.34% year-over-year, up +1185.18% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash from operations is currently -71.01% below its historical high of $5.12B set on
- 3-Year Low Comparison
- GSK quarterly cash from operations is +1185.18% above its 3-year low of $115.43M reached on an earlier date
- Sector Comparison
- GSK quarterly cash from operations is higher than 98.03% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash From Operations | $1.48B | -45.9% | +4.3% | +1185.2% | +340.9% | |
| Annual Cash From Operations | $9.62B | – | +23.7% | +17.9% | -1.9% | |
| TTM Cash From Operations | $9.72B | +0.6% | +20.2% | +98.6% | +8.2% | |
| Price | $49.81 | -14.8% | +36.0% | +37.3% | +27.9% | |
| Quarterly Cash From Investing | -$1.78B | +44.0% | -12.9% | -160.8% | -2540.3% | |
| Quarterly Cash From Financing | $229.06M | -79.0% | -81.5% | +192.0% | +112.9% | |
| Quarterly Free Cash Flow | $886.58M | -36.5% | +3.4% | +268.1% | +684.5% | |
| Quarterly CAPEX | $596.89M | -55.7% | +5.8% | -7.1% | +22.3% | |
| Quarterly Net Income | $2.48B | +156.3% | +11.0% | +25.0% | +42.6% |
Quarterly Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.03B | -51.1% | |
| 3Y | $3.62B | -59.0% | |
| 5Y | $4.70B | -68.5% | |
| All | $5.12B | -71.0% |
Quarterly Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.42B | N/A | +4.3% |
| 3Y | $115.43M | N/A | +1185.2% |
| 5Y | $115.43M | +1185.2% | |
| All | -$2.73B | +154.3% |
Quarterly Cash From Operations History
FAQ
What is the current quarterly cash from operations of GSK?
As of today, GSK quarterly cash from operations is $1.48B
What is GSK quarterly cash from operations most recent change?
GSK quarterly cash from operations was down -45.93% on March 31, 2026
What is 1-year change in GSK quarterly cash from operations?
GSK quarterly cash from operations is up +4.34% year-over-year
How far is GSK quarterly cash from operations from its all-time high?
GSK quarterly cash from operations is currently -71.01% below its historical high of $5.12B set on December 31, 2018
How does GSK quarterly cash from operations rank versus sector peers?
GSK quarterly cash from operations is higher than 98.03% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
TTM CFO
$9.72B$61.71M+0.64%
Summary
- Current Value
- As of today, GSK TTM cash from operations is $9.72B, up +0.64% on
- Historical Performance
- GSK TTM cash from operations is up +20.17% year-over-year, up +98.56% over the past 3 years
- All-Time High Comparison
- GSK TTM cash from operations is currently -25.79% below its historical high of $13.10B set on
- 3-Year Low Comparison
- GSK TTM cash from operations is +109.05% above its 3-year low of $4.65B reached on
- Sector Comparison
- GSK TTM cash from operations is higher than 98.69% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM Cash From Operations | $9.72B | +0.6% | +20.2% | +98.6% | +8.2% | |
| Annual Cash From Operations | $9.62B | – | +23.7% | +17.9% | -1.9% | |
| Quarterly Cash From Operations | $1.48B | -45.9% | +4.3% | +1185.2% | +340.9% | |
| Price | $49.81 | -14.8% | +36.0% | +37.3% | +27.9% | |
| TTM Cash From Investing | -$7.94B | -2.6% | -154.8% | -19.3% | -391.3% | |
| TTM Cash From Financing | -$3.17B | -46.9% | -13.1% | +64.9% | +74.5% | |
| TTM Free Cash Flow | $5.74B | +0.5% | +30.7% | +154.0% | -5.4% | |
| TTM CAPEX | $3.98B | +0.8% | +7.7% | +51.0% | +36.5% | |
| TTM Net Income | $8.53B | +3.0% | +85.4% | +48.7% | +10.5% |
TTM Cash From Operations Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $9.75B | -0.3% | |
| 3Y | $9.75B | -0.3% | |
| 5Y | $13.10B | -25.8% | |
| All | $13.10B | -25.8% |
TTM Cash From Operations Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $8.09B | N/A | +20.2% |
| 3Y | $4.65B | +109.0% | |
| 5Y | $4.65B | +109.0% | |
| All | $1.75B | +455.8% |
TTM Cash From Operations History
FAQ
What is the current TTM cash from operations of GSK?
As of today, GSK TTM cash from operations is $9.72B
What is GSK TTM cash from operations most recent change?
GSK TTM cash from operations was up +0.64% on March 31, 2026
What is 1-year change in GSK TTM cash from operations?
GSK TTM cash from operations is up +20.17% year-over-year
How far is GSK TTM cash from operations from its all-time high?
GSK TTM cash from operations is currently -25.79% below its historical high of $13.10B set on June 30, 2022
How does GSK TTM cash from operations rank versus sector peers?
GSK TTM cash from operations is higher than 98.69% of companies in Healthcare sector
When is GSK next earnings release?
The next earnings release for GSK is on
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk